Generally, Ozempic claims fall into four categories: gastrointestinal issues, blood clots, aspiration, and vision loss
Trulicity activates one hormone receptor (GLP-1), while Mounjaro activates two (GLP-1 and GIP)
In comparison to the placebo group, more participants in the semaglutide group stopped taking the medication due to gastrointestinal problems
Methodological guidelines and publications of benefit-risk assessment for health technology assessment: a scoping review
This tight timing helps your body absorb the medicine properly
GI symptoms GI symptoms, the most frequently reported adverse effect, results from semaglutides delayed gastric emptying (the drugs action on appetite regulation)